(P202) Gains in Weight Loss Pharmacotherapy

Obesity is a chronic and progressive disease that may require a combination of pharmacotherapeutic interventions, dietary modifications, and an overall health coaching approach. Almost a half of the US population is considered to live with obesity and it has the 3rd largest direct economic impact on the world's economy. It is associated with 60+ comorbidities and shortens lifespans and even modest weight loss has clinical benefits. There are newer pharmacologic agents that treat chronic obesity and guidelines that describe the use of nonpharmacologic and pharmacologic modalities. This poster presentation will showcase obesity as a chronic disease and describe the optimal approach to treatment.